Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,325 | 72,904 | 78,660 | 86,037 | 84,057 |
| TOTAL | $66,456 | $74,506 | $79,520 | $87,068 | $85,373 |
| Non-Current Assets | |||||
| PPE Net | 317 | 364 | 412 | 460 | 496 |
| Other Non-Current Assets | 1,874 | 2,029 | 2,182 | 2,333 | 2,483 |
| TOTAL | $2,191 | $2,393 | $2,594 | $2,793 | $2,979 |
| Total Assets | $68,647 | $76,899 | $82,114 | $89,861 | $88,352 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,520 | 7,568 | 7,195 | 9,177 | 7,513 |
| TOTAL | $7,110 | $8,148 | $7,755 | $9,728 | $8,064 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 836 | 984 | 1,139 | 1,284 | 1,414 |
| TOTAL | $35,843 | $35,993 | $36,151 | $36,298 | $36,431 |
| Total Liabilities | $42,953 | $44,141 | $43,906 | $46,026 | $44,495 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,196 | 31,196 | 31,196 | 31,154 | 29,783 |
| Common Shares | 31 | 31 | 31 | 31 | 29 |
| Retained earnings | -391,764 | -375,826 | -369,174 | -357,606 | -346,253 |
| TOTAL | $25,694 | $32,758 | $38,208 | $43,835 | $43,857 |
| Total Liabilities And Equity | $68,647 | $76,899 | $82,114 | $89,861 | $88,352 |